MedPath
HSA Approval

AA-AMILZIDE TABLET

SIN06538P

AA-AMILZIDE TABLET

AA-AMILZIDE TABLET

August 22, 1991

PHARMAFORTE SINGAPORE PTE LTD

PHARMAFORTE SINGAPORE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPHARMAFORTE SINGAPORE PTE LTD
Licence HolderPHARMAFORTE SINGAPORE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

C03EA01

hydrochlorothiazide and potassium-sparing agents

Manufacturer Information

PHARMAFORTE SINGAPORE PTE LTD

APOTEX INC

Active Ingredients

AMILORIDE HCl

5 mg

Amiloride

HYDROCHLOROTHIAZIDE

50 mg

Hydrochlorothiazide

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

AA-AMILZIDE TABLET - HSA Approval | MedPath